Stanford researchers have developed a novel, cell-free platform for rapid and high-throughput protein function analysis. This technology harnesses hydrogel bead-based emulsification to parallelize and screen DNA-encoded protein libraries in a scalable, efficient manner.
Stanford researchers have developed Microbe-Independent Deep Assembly and Screening (MIDAS-M), a novel platform that dramatically accelerates the cloning of protein variants and its analysis in mammalian cells.
Stanford researchers have developed a general system to regulate the activities of specific proteins in mammalian cells using cell-permeable, synthetic molecules.
Stanford researchers have developed a novel methodology for the high-throughput expression and kinetic characterization of numerous enzyme variants in parallel using microfluidic droplet arrays.
Many applications in cell therapy, synthetic biology, and gene therapy require extensive cell engineering, often with multiple vectors due to limitations in packaging capacity.
Researchers at Stanford University have developed an affinity capture technique for top-down protein analysis that directly couples biolayer interferometry (BLI) with high resolution mass spectrometry (HR-MS).
Stanford researchers have patented protein stability regulation methods using destabilizing domains (DDs) optimized for use in humans. The ability to control specific protein abundance in cells is a powerful tool for gene therapy and investigating biological behavior.